Molecular Formula | C15H12N2OS2 |
Molar Mass | 300.4 |
Density | 1.40±0.1 g/cm3(Predicted) |
Melting Point | 198-199℃ |
Boling Point | 581.3±45.0 °C(Predicted) |
Appearance | powder to crystal |
Color | White to Orange to Green |
pKa | 15.12±0.30(Predicted) |
Storage Condition | Sealed in dry,2-8°C |
In vitro study | A-205804 exhibits Cellular Toxicities for HUVEC with an IC 50 of 152 μM. A-205804 is an effective inhibitor of cell-cell adhesion in an in vitro flow experiment, demonstrating relevance in a model physiological system. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.329 ml | 16.645 ml | 33.289 ml |
5 mM | 0.666 ml | 3.329 ml | 6.658 ml |
10 mM | 0.333 ml | 1.664 ml | 3.329 ml |
5 mM | 0.067 ml | 0.333 ml | 0.666 ml |
biological activity | A-205804 is an orally effective, potent and selective lead inhibitor that inhibits the expression of E-selectin and ICAM-1, the IC50 for E-selectin and ICAM-1 effects were 20 nM and 25 nM, respectively. A- 205804 can be used in the study of chronic inflammatory diseases. |
Target | IC50: 20 nM (E-selectin), 25 nM (ICAM-1) |
Animal Model: | C57BL/6 mice Rat |
Dosage: | 10 mg/kg 5 mg/kg (Pharmacokinetic Analysis) |
Administration: | Oral administration, 3 times per week, for 2 weeks Oral administration |
Result: | Efficiently decreased the expression of E-selectin on the endothelial vascular niche cells t 1/2 = 1 hour |